IgM antibodies directed against glycans composed of alpha-glucose disaccharides have been found in MS patients and demonstrated to distinguish relapsing-remitting MS patients from those with other neurological diseases [13]–[15]. The gene discussed is CD40LG; the disease is myeloid sarcoma.